Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-CE-22-011: Understanding Polydrug Use Risk and Protective Factors, Patterns, and Trajectories to Prevent Drug Overdose

Closed Closed February 24, 2022 Opportunity RFA-CE-22-011 ☆ Save

This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2021.

• Award ceiling$350,000
• Total funding$5.3 million
• Expected awards5
• Cost sharingNot required
• Funding typeGrant

Key dates

Who can apply

This opportunity was open to any type of organization.

See Section III. Eligibility Information

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Past Injury Prevention and Control Research and State and Community Based Programs awards averaged $2.2 million; this notice allows up to $350,000 per award.
• Most of the program's money (76% over five years) went to state and local governments.
• No cost sharing or match is required.

What the grant funds

The Centers for Disease Control and Prevention (CDC) National Centers for Injury Prevention and Control (NCIPC) is soliciting investigator initiated research to improve our understanding of risk and protective factors, patterns, and trajectories related to polydrug use, with a focus on polydrug combinations most likely to result in nonfatal overdose or death, such as combinations including synthetic opioids. Polydrug combinations of interest include the following: Co-use of multiple opioids, knowingly or unknowingly (i.e., due to unknown adulterants) Co-use of non-opioid drugs (particularly psychostimulants [e.g., methamphetamine], cocaine, and benzodiazepines) AND opioids, knowingly or unknowingly Co-use of other combinations of drugs that may result in drug overdose Applicants should focus on identifying risk and protective factors, AND patterns, AND trajectories of polydrug use for either 1) the general population OR 2) one or more of the following subpopulations of interest: Persons who have experienced acute or chronic pain and used prescription opioids to manage their pain Persons who use cannabis, either medically or non-medically Applicants may also use prior research or preliminary data to justify an alternate subpopulation of interest, such as other groups which have been disproportionately affected by overdose. The overall goal of this research is to better understand risk and protective factors for and patterns and trajectories of polydrug use in order to inform targeted drug use and overdose prevention efforts.

Category: Health.

Applying now

This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.